Bronchodilator
Mostrando 25-36 de 219 artigos, teses e dissertações.
-
25. Parâmetros espirométricos e níveis de IFN-y e IL-5 no escarro induzido de pacientes com asma ou rinite alérgicas
Asthma and allergic rhinitis are mediated by IgE antibodies through the development of allergen-specific Th2 cells in genetically predisposed and sensitized subjects. Asthma and rinithis are frequently associated, suggesting the concept of one airway, one disease. The aims of this study were to analyze spirometrics parameters and IFN-γ and IL-5 levels i
Publicado em: 2007
-
26. AvaliaÃÃo dos resultados clÃnicos e humanÃsticos de um plano de atenÃÃo farmacÃutica em pacientes asmÃticos / Assessment from the outcomes clinical and humanistic by one plane of pharmaceutical care of a asthmatic patients
The high prevalence of poorly controlled asthma and the associated high morbimortality have been shown to be related mainly to under-diagnosis and inadequate treatment of this condition. This present significant cost adding further burden on the healthcare budget The consequences of poorly controlled asthma are repeated clinic visits repeated emergency room
Publicado em: 2007
-
27. The exercise of bronchodilatadors and oxygen alone and in combination on exercise performance in COPD / "Efeito da oxigenoterapia e dos broncodilatadores no desempenho físico de pacientes com DPOC"
Our objective was assess the effect of oxygen (O2) and bronchodilator (BD) on reduce exertional breathlessness and improve exercise tolerance in patients with COPD. Nebulization of 5 mg of salbutamol plus 500 ug ipratropium bromide followed by a six-minute walking test while breathing O2 were studient in 28 patients with severe COPD, breathless on exertion a
Publicado em: 2006
-
28. Agentes antiasmáticos modernos: antagonistas de receptores de leucotrienos cisteínicos
In the early 1990s numerous clinical trials with antileukotriene drugs confirmed the hypothesis that cysteinyl leukotrienes are important bronchoconstrictor agents in asthma. Newly released"antiasthmatic medications include antileukotriene agents which function either by blocking the interaction of leukotrienes with receptors or by inhibiting leukotriene syn
Química Nova. Publicado em: 2002-09
-
29. Estudo da função das glandulas supra-renais em pacientes asmaticos em uso de beclometasona e fluticasona
Bronchial asthma is widely known as a chronic inflammatory disease of the airways and corticosteroids are the most effective drugs for asthma treatment since they block many of the inflammatory mechanisms of the disease and they have prophylactic action. In the last decades, with the introduction of inhaled corticotherapy, there was a reduction in the period
Publicado em: 2001
-
30. Variability of bronchodilator response and effects of inhaled corticosteroid treatment in obstructive airways disease. Dutch CNSLD Study Group.
BACKGROUND--In the day to day care of obstructive airways diseases (asthma and chronic obstructive pulmonary disease) important decisions such as disease classification and choice of therapy are based on assessment of the bronchodilator response. However, surprisingly little is known of the long term course of the bronchodilator response in patients with obs
-
31. Selective cardiac sympathetic blockade as an adjunct to bronchodilator therapy
It has been shown in nine asthmatic patients that practolol, a selective cardiac beta-adrenergic antagonist, successfully blocks the unwanted tachycardia and palpitation following isoprenaline inhalation without hindering the beneficial bronchodilator action of the drug. Practolol is a useful adjunct to bronchodilator therapy in the management of bronchial a
-
32. Bronchodilator treatment and deaths from asthma: case-control study
Objective To investigate the association between bronchodilator treatment and death from asthma.
BMJ Publishing Group Ltd..
-
33. Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group.
BACKGROUND: There is no agreement on how a bronchodilator response should be expressed. Ideally, the index used should be able to distinguish asthma from chronic obstructive lung disease and be independent of initial FEV1. METHODS: Two hundred and seventy four adults (aged 18-60 years) outpatients with obstructive airways disease were studied. Patients were
-
34. Perception of airflow obstruction and associated breathlessness in normal and asthmatic subjects: correlation with anxiety and bronchodilator needs.
BACKGROUND--Perception of bronchoconstriction varies between individuals and its determinants remain to be identified. The perception of airflow obstruction and breathlessness during induced bronchoconstriction was studied, and the effects of anxiety, repetition of the stimulus, and bronchodilator needs on these measurements were examined in normal and asthm
-
35. Effect of inhaled thiorphan, a neutral endopeptidase inhibitor, on the bronchodilator response to inhaled atrial natriuretic peptide (ANP).
BACKGROUND: The hormone atrial natriuretic peptide (ANP) causes bronchodilation and partially protects against direct and indirect bronchial challenges. Both in vitro and in vivo studies have found that the protective effect of ANP against bronchoconstriction is enhanced by inhibition of the enzyme neutral endopeptidase (NEP). It was hypothesised that pretre
-
36. Effect of particle size of bronchodilator aerosols on lung distribution and pulmonary function in patients with chronic asthma.
The particle size of bronchodilator aerosols may be important in determining the site of deposition in the lung and their therapeutic effect. The distribution of aerosols (labelled with technetium-99m diethylene triamine pentacetic acid) of two different particle sizes has been studied by gamma camera imaging. The particles had mass median aerodynamic diamet